Learn More
Medchemexpress LLC Cpn-219 | 2240202-02-0 | 99.08% | 849.08 | 10 MG

Supplier: Medchemexpress LLC HYP303010MG
CPN-219 is a next-generation hexapeptidic NMUR2 agonist. It achieves dose-dependent and selective activation of NMUR2 with an EC50 value of 2.2 nM. For research purposes, CPN-219 has shown an ability to suppress body weight gain in mice through intranasal administration in a dose-dependent manner.
- Acts as a next-generation hexapeptidic NMUR2 agonist
- Achieves dose-dependent and selective activation of NMUR2
- EC50 value of 2.2 nM
- Suppresses body weight gain in mice via intranasal administration
- Ineffective via intraperitoneal injection in mice at 250 μg
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.